In recent years, AQP9 implication in a variety of disorders, including liver injury [28], inflammation [29], cancer [30,31,32,33,34,35], and altered immune response [36,37,38], revealed AQP9 as a promising drug target and a diagnostic/prognostic biomarker in clinical medicine. This evidence concerns the gene AQP9 and cancer.